Samsung Biologics

207940.KO

670.75 USD

-9.01

-1.33%

Overview

Last close

670.75 usd

Market cap

31.05B usd

52 week high

739.56 usd

52 week low

634.23 usd

Target price

670.75 usd

Valuation

P/E

N/A

Forward P/E

34.7222

Price/Sales

13.8757

Price/Book Value

9.145

Enterprise Value

45.33B usd

EV/Revenue

14.8305

EV/EBITDA

24.2976

Key financials

Revenue TTM

3.23B usd

Gross Profit TTM

1.78B usd

EBITDA TTM

1.81B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

7.67B usd

Net debt

533.63M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.